A carregar...
A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA
OBJECTIVE: To describe an unusual immune-related adverse event (irAE), acquired generalized lipodystrophy (AGL), from checkpoint inhibitor therapy in a patient treated with pembrolizumab. METHODS: This is a case report of a 67-year-old male with metastatic melanoma who was treated with pembrolizumab...
Na minha lista:
| Publicado no: | AACE Clin Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association of Clinical Endocrinologists
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279776/ https://ncbi.nlm.nih.gov/pubmed/32524008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0234 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|